Correlation between serum levels of RANKL with osteoporosis in patients with beta thalassemia major
Author | Fatemeh Jafari | en |
Author | Azita Azarkeivan | en |
Author | Davod Bashash | en |
Author | Ali Akbar Khadem Maboodi | en |
Author | mohsen hamidpour | en |
Orcid | mohsen hamidpour [0000-0002-3658-1551] | en |
Issued Date | 2019-03-31 | en |
Abstract | Introduction: Osteoporosis is a major problem in patients with B-thalassemia major. Osteoclasts hyperactivity, which increases serum levels of receptor activator of nuclear factor kappa-Β ligand (RANKL), plays an important role in the pathogenesis of osteoporosis in these patients. The aim of this study was to study the relationship between serum levels of RANKL and osteoporosis in patients with beta thalassemia major. Materials and Methods: 52 patients with beta thalassemia major and 22 people with thalassemia minor without any osteoporosis symptoms as controls were entered the study. Six ml of peripheral blood was obtained for hematologic and serum RANKL measurements. Results: The mean of bone mineral density in patients were 0.57 ± 0.3 and 0.69 ± 0.11 in femur and vertebra, respectively. There were significant differences between hematologic parameters of patients and controls. The mean of patient’s serum RANKL level was 198.4pg/mL and in controls was 112.25pg/mL. There was a correlation between decrease of femur BMD (p | en |
DOI | https://doi.org/ | en |
Keyword | B- Thalassemia Major | en |
Keyword | Osteoporosis | en |
Keyword | Hematologic Parameters | en |
Keyword | RANKL | en |
Keyword | بتاتالاسمی ماژور | en |
Keyword | استئوپورزیس | en |
Keyword | پارامترهای هماتولوژیک | en |
Publisher | Brieflands | en |
Title | Correlation between serum levels of RANKL with osteoporosis in patients with beta thalassemia major | en |
Type | Research Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- article-1-4790-fa.pdf.pdf
- Size:
- 703.83 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF